Literature DB >> 16051552

A 90-day toxicological evaluation of 1,5-anhydro-d-fructose in Sprague-Dawley rats.

Jie Mei1, Shukun Yu, Bo Ahrén.   

Abstract

1,5-anhydro-d-fructose (1,5-AF) is a novel monosaccharide produced by the action of alpha-1,4-glucan lyase (EC 4.2.2.13) on glycogen, starch, or related substrates such as maltose and maltosaccharides. 1,5-AF is of interest as a compound to be used as a food supplement because of its antioxidant, antimicrobial, and antidiabetic properties. This enforces the safety of 1,5-AF and therefore, in the current study, four groups of male and female Sprague-Dawley rats were provided with 1,5-AF in the drinking water (at 0 or 1.0 g/kg body weight daily) for a period of 90 days (n=10 in each group). All the animals survived, and no clinical signs of toxicity or alterations in hematological or clinical chemistry parameters were observed. Furthermore, organ weight and histopathological examination of brain, heart, urinary bladder, gastrointestinal tract, and pancreas were normal after 1,5-AF treatment. Moreover, there was no change in food consumption, water intake, or body weight gain in rats receiving 1,5-AF. In conclusion, administration of 1,5-AF did not induce any significant toxicological effects and, therefore, 1,5-AF seems safe to administer in vivo over a long period of time.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16051552     DOI: 10.1081/dct-200064458

Source DB:  PubMed          Journal:  Drug Chem Toxicol        ISSN: 0148-0545            Impact factor:   3.356


  2 in total

1.  Study on administration of 1,5-anhydro-D-fructose in C57BL/6J mice challenged with high-fat diet.

Authors:  Jie Mei; Shukun Yu; Bo Ahrén
Journal:  BMC Endocr Disord       Date:  2010-10-19       Impact factor: 2.763

2.  Potential roles of 1,5-anhydro-D-fructose in modulating gut microbiome in mice.

Authors:  Takashi Ito; Takaaki Totoki; Seiya Takada; Shotaro Otsuka; Ikuro Maruyama
Journal:  Sci Rep       Date:  2021-10-04       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.